# Nektar Therapeutics: Form 8-K, filed Jan 27, 2026

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2026-01-27
- Accepted by EDGAR: Jan 27, 2026, 16:02 ET
- Period: 2026-01-27
- Accession: 0001213900-26-008210
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000121390026008210/ea0274309-8k_nektar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000121390026008210/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000121390026008210/ea0274309-8k_nektar.htm

Filed Jan 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-008210. Last ingested by Listed: Nov 10, 2026, 17:19 ET. No prices; not investment advice.